Dr. Reddy's Laboratories (RDY) News Today $15.89 +0.26 (+1.66%) Closing price 06/10/2025 03:59 PM EasternExtended Trading$15.89 +0.00 (+0.01%) As of 05:19 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock RDY Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Dr. Reddy's Laboratories rallies Tuesday, outperforms competitorsJune 10 at 8:42 AM | marketwatch.comDr. Reddy's Laboratories Reaches Analyst Target PriceJune 8 at 12:15 PM | nasdaq.comDr. Reddy's Laboratories (NYSE:RDY) Upgraded at Hsbc Global ResJune 7, 2025 | americanbankingnews.comDr. Reddy's Laboratories (NYSE:RDY) Upgraded to "Buy" at HSBCJune 7, 2025 | americanbankingnews.comHSBC Upgrades Dr. Reddy's Laboratories Limited - Depositary Receipt () (RDY)June 6, 2025 | msn.comDr. Reddy's Laboratories (NYSE:RDY) Upgraded by Hsbc Global Res to "Strong-Buy" RatingHsbc Global Res raised Dr. Reddy's Laboratories from a "hold" rating to a "strong-buy" rating in a report on Thursday.June 6, 2025 | marketbeat.comHSBC Upgrades Dr. Reddy’s Laboratories Limited (RDY) to Buy from HoldJune 5, 2025 | msn.comDr. Reddy's Laboratories rallies Thursday, outperforms competitorsJune 5, 2025 | marketwatch.comHSBC upgrades Dr Reddy’s on weight loss drug semaglutide-driven earnings reboundJune 5, 2025 | in.investing.comDr. Reddy’s stock rises on biosimilar collaboration with AlvotechJune 5, 2025 | investing.comDr. Reddy's Laboratories (NYSE:RDY) Shares Gap Up - Time to Buy?Dr. Reddy's Laboratories (NYSE:RDY) Shares Gap Up - Should You Buy?June 5, 2025 | marketbeat.comDr. Reddy's Laboratories (NYSE:RDY) Raised to "Buy" at HSBCHSBC raised Dr. Reddy's Laboratories from a "hold" rating to a "buy" rating and set a $16.90 target price for the company in a research report on Thursday.June 5, 2025 | marketbeat.comAlvotech and Dr. Reddy's Enter into Collaboration to Co-Develop Biosimilar Candidate to Keytruda® (pembrolizumab)June 5, 2025 | businesswire.comAlvotech and Dr. Reddy’s Enter into Collaboration to Co-Develop Biosimilar Candidate to Keytruda® (pembrolizumab)June 5, 2025 | finance.yahoo.comAlvotech and Dr. Reddy’s partner to co-develop biosimilar candidate for Keytruda (pembrolizumab)June 5, 2025 | msn.comDr. Reddy’s Labs ADR Stock Price HistoryJune 4, 2025 | investing.comDr. Reddy's Laboratories rises Wednesday, underperforms marketJune 4, 2025 | marketwatch.comTwo Sigma Advisers LP Acquires 23,700 Shares of Dr. Reddy's Laboratories Limited (NYSE:RDY)Two Sigma Advisers LP raised its position in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 254.8% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 33,000 shares of the company'sJune 4, 2025 | marketbeat.comDr. Reddy's Laboratories slips Tuesday, outperforms competitorsJune 3, 2025 | marketwatch.comParallel Advisors LLC Sells 23,725 Shares of Dr. Reddy's Laboratories Limited (NYSE:RDY)Parallel Advisors LLC lowered its position in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 32.6% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 49,065 shares of the company's stoJune 3, 2025 | marketbeat.comWellington Management Group LLP Acquires 727,665 Shares of Dr. Reddy's Laboratories Limited (NYSE:RDY)Wellington Management Group LLP increased its holdings in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 431.8% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 896,165 shares of the company'June 2, 2025 | marketbeat.comAmeriprise Financial Inc. Lowers Stock Holdings in Dr. Reddy's Laboratories Limited (NYSE:RDY)Ameriprise Financial Inc. cut its position in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 42.8% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 73,005 shares of the company's stock after selling 54,667 shares during the period. Ameriprise FiJune 2, 2025 | marketbeat.comZacks Research Has Pessimistic Outlook of RDY Q3 EarningsJune 2, 2025 | americanbankingnews.comZacks Research Issues Pessimistic Outlook for RDY EarningsDr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) - Zacks Research lowered their Q3 2026 earnings per share (EPS) estimates for Dr. Reddy's Laboratories in a research report issued on Friday, May 30th. Zacks Research analyst R. Department now expects that the company will post earnings peJune 2, 2025 | marketbeat.com63,775 Shares in Dr. Reddy's Laboratories Limited (NYSE:RDY) Purchased by Squarepoint Ops LLCSquarepoint Ops LLC acquired a new position in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm acquired 63,775 shares of the company's stock, valued at approximately $1,007,000. A nuJune 1, 2025 | marketbeat.comBoston Common Asset Management LLC Increases Stake in Dr. Reddy's Laboratories Limited (NYSE:RDY)Boston Common Asset Management LLC raised its stake in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 194.9% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 53,2May 31, 2025 | marketbeat.comNorthCrest Asset Manangement LLC Has $869,000 Position in Dr. Reddy's Laboratories Limited (NYSE:RDY)NorthCrest Asset Manangement LLC raised its stake in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 395.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 55,025 shares of the company's stMay 31, 2025 | marketbeat.comDr. Reddy's Laboratories climbs Friday, outperforms marketMay 30, 2025 | marketwatch.comDr. Reddy's Laboratories climbs Friday, outperforms marketMay 30, 2025 | marketwatch.comB. Riley Wealth Advisors Inc. Increases Holdings in Dr. Reddy's Laboratories Limited (NYSE:RDY)B. Riley Wealth Advisors Inc. increased its position in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 829.5% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 57,350 shares of the companMay 30, 2025 | marketbeat.comDr. Reddy's Laboratories (RDY) Shares Cross Above 200 DMAMay 29, 2025 | nasdaq.comDr. Reddy's Laboratories , outperforms marketMay 28, 2025 | marketwatch.comDr. Reddy's Laboratories Limited (NYSE:RDY) Shares Bought by Pinnacle Wealth Planning Services Inc.Pinnacle Wealth Planning Services Inc. raised its stake in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 203.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 26,744 shares of the company's sMay 28, 2025 | marketbeat.comMan Group plc Reduces Stock Position in Dr. Reddy's Laboratories Limited (NYSE:RDY)Man Group plc lessened its stake in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 24.7% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 156,966 shares of the company's stock afteMay 25, 2025 | marketbeat.comVident Advisory LLC Has $2.39 Million Stock Position in Dr. Reddy's Laboratories Limited (NYSE:RDY)Vident Advisory LLC increased its holdings in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 535.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 151,331 shares of the company's stock after buying an aMay 24, 2025 | marketbeat.comQuantinno Capital Management LP Increases Stake in Dr. Reddy's Laboratories Limited (NYSE:RDY)Quantinno Capital Management LP increased its holdings in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 429.7% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 107,189 shares of the companyMay 24, 2025 | marketbeat.comDr. Reddy's Laboratories Limited (NYSE:RDY) Shares Bought by Deutsche Bank AGDeutsche Bank AG boosted its holdings in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 311.9% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 171,602 shares of theMay 24, 2025 | marketbeat.comThornburg Investment Management Inc. Purchases 48,763 Shares of Dr. Reddy's Laboratories Limited (NYSE:RDY)Thornburg Investment Management Inc. raised its position in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 232.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 69,751 shares of the company's stoMay 21, 2025 | marketbeat.comDr. Reddy's Laboratories Limited (NYSE:RDY) Holdings Raised by Royal Bank of CanadaRoyal Bank of Canada increased its position in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 403.1% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 10,037,246 shares of the company's stock aftMay 21, 2025 | marketbeat.comDr. Reddy's Laboratories Limited (NYSE:RDY) Shares Acquired by Millennium Management LLCMillennium Management LLC lifted its position in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 1,676.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,837,632 shares of tMay 19, 2025 | marketbeat.comEthic Inc. Buys 18,655 Shares of Dr. Reddy's Laboratories Limited (NYSE:RDY)Ethic Inc. grew its stake in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 422.2% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 23,073 shares of the company's stock after buying an additional 18,655 shares duMay 19, 2025 | marketbeat.comBank of America Corp DE Acquires 1,057,584 Shares of Dr. Reddy's Laboratories Limited (NYSE:RDY)Bank of America Corp DE raised its holdings in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 123.1% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,916,425 shares of the company's stocMay 19, 2025 | marketbeat.comD. E. Shaw & Co. Inc. Acquires 309,239 Shares of Dr. Reddy's Laboratories Limited (NYSE:RDY)D. E. Shaw & Co. Inc. boosted its position in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 256.3% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 429,887 shares of the company's stock after purchasMay 18, 2025 | marketbeat.comOMERS ADMINISTRATION Corp Grows Stock Holdings in Dr. Reddy's Laboratories Limited (NYSE:RDY)OMERS ADMINISTRATION Corp grew its stake in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 637.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 159,535 shareMay 17, 2025 | marketbeat.comDr. Reddy's Continues To Be A Good Buy At Current ValuationMay 15, 2025 | seekingalpha.comLogan Capital Management Inc. Boosts Stake in Dr. Reddy's Laboratories Limited (NYSE:RDY)Logan Capital Management Inc. raised its stake in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 236.1% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 42,065 shares of the company's stock after buyinMay 15, 2025 | marketbeat.comLaird Norton Wetherby Wealth Management LLC Grows Position in Dr. Reddy's Laboratories Limited (NYSE:RDY)Laird Norton Wetherby Wealth Management LLC raised its holdings in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 376.9% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 200,098May 15, 2025 | marketbeat.comBalyasny Asset Management L.P. Has $1.64 Million Stock Holdings in Dr. Reddy's Laboratories Limited (NYSE:RDY)Balyasny Asset Management L.P. grew its position in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 781.7% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 103,850 shares of the company's stock after purchasing an additionaMay 15, 2025 | marketbeat.comNorthern Trust Corp Buys 1,370,366 Shares of Dr. Reddy's Laboratories Limited (NYSE:RDY)Northern Trust Corp boosted its position in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 1,822.1% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,445,572 shares of the comMay 15, 2025 | marketbeat.comDr. Reddy's Laboratories Limited (NYSE:RDY) Shares Bought by Stifel Financial CorpStifel Financial Corp grew its holdings in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 592.0% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 33,117 shares of the company's stock after purchasingMay 15, 2025 | marketbeat.com Get Dr. Reddy's Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for RDY and its competitors with MarketBeat's FREE daily newsletter. Email Address RDY Media Mentions By Week RDY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RDY News Sentiment▼0.241.01▲Average Medical News Sentiment RDY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RDY Articles This Week▼215▲RDY Articles Average Week Get Dr. Reddy's Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for RDY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Takeda Pharmaceutical News argenx News Beigene News BioNTech News Teva Pharmaceutical Industries News Summit Therapeutics News Genmab A/S News Intra-Cellular Therapies News Moderna News Ascendis Pharma A/S News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:RDY) was last updated on 6/11/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dr. Reddy's Laboratories Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Dr. Reddy's Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
